Linkage to Hepatitis C Virus Care among HIV/HCV Co-infected Substance Users

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

Using the existing CTN-0049 cohort as a research platform, the proposed RCT will assess the effectiveness of an efficacious linkage to care intervention for HIV/HCV co-infected substance users. Linkage to care will be operationalized as receipt of clinical evaluation/treatment for HCV infection. Secondary objectives will be to assess: 1) relative success at each step in the cascade, 2) engagement in substance use treatment and HIV care, and 3) HIV viral suppression.

CTN Protocol ID:

CTN-0064

ClinicalTrials.gov ID:

NCT02641158

Principal Investigator(s)

Lisa Metsch, Ph.D.
Stephen Smith Professor and Chair of Sociomedical Sciences Department
Sociomedical Sciences Mailman School of Public Health
Columbia University
722 West 168th Street, Room 918
New York, NY 10032
United States
Lm2892@columbia.edu